Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Hair growth is influenced by factors like genetics and nutrition, and more research is needed to understand hair loss and growth mechanisms.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Some skin diseases and their treatments can negatively affect male fertility.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

Some alternative therapies for vitiligo show promise but need more research.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Belimumab effectively controls SLE disease activity and reduces steroid use.